• Telephone : (855) 802-0299
  • Email Address: IR@GreenHygienics.com
  • Head Office: | POWAY, CA | 92064

Monthly Archives: October 2020

SAN DIEGO, Oct. 14, 2020 /PRNewswire/ -- Green Hygienics Holdings Inc. (OTCQB: GRYN) ("GHH" or the "Company"), is pleased to announce that effective August 26, 2020, the Company is registered with the U.S. Food and Drug Administration (the "FDA") pursuant to the Federal Food Drug and Cosmetic Act, as amended by the Bioterrorism Act of 2002.

The registration helps the FDA with information on the origin and distribution of food and supplement products and thereby aid in the detection and quick response to actual or potential threats to the U.S. food supply. FDA Registration information also helps US FDA to notify the food establishment that may be affected by the actual or potential threat.

"The achievement of FDA Registration strengthens our Company's core mission to provide product efficacy to the Pharmaceutical industry and consumers alike. The Company is well positioned to instill consumer confidence and change the landscape of the industry by bringing safe and consistent products to market. With our previously announced USDA Organic Certification and FDA Facility Registration, we are well-positioned to continue to innovate through the research our teams are involved in and drive new commercial products entirely complaint to USDA and FDA regulatory requirements," stated Dr. Levan Darjania, Chief Scientific Officer of Green Hygienics Holdings Inc.



About Green Hygienics Holdings Inc.

Green Hygienic Holdings Inc. (OTCQB: GRYN) ("GHH" or the "Company"), a California based innovative technology driven enterprise focused on the high standard cultivation and processing of industrial hemp and manufacturing of pharmaceutical grade bioactive cannabinoids. The GHH mission is to adhere to the highest standards of operations in consistently delivering safe and premium quality products to consumers as well as to partnering CPG and pharmaceutical companies.

The Company intends to be a leader in compliances and capabilities in the hemp and cannabinoid supply marketplace. Using state of the art technologies, GHH intends to open up a whole new world of novel cannabinoids and targeted bio-delivery technologies never before explored, solving the issues of stability, pharmacokinetics, biological tissue penetration, and bioavailability. We are building a team of visionary agrotechnology, pharmaceutical and life scientists working at the intersection of nutraceutical, cosmeceutical and pharmaceutical technologies with a goal to improve the lives of billions.

For more information, please visit: www.GreenHygienics.com

CAUTIONARY STATEMENT CONCERNING FORWARD LOOKING STATEMENTS This document contains forward-looking statements. In addition, from time to time, we or our representatives may make forward-looking statements orally or in writing. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Such forward-looking statements relate to future events or our future performance, including: our financial performance and projections; our growth in revenue and earnings; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as "may," "should," "expects," "anticipates," "contemplates," "estimates," "believes," "plans," "projected," "predicts," "potential," or "hopes" or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of the Company; our ability to keep pace with new technology and changing market needs; and the competitive environment of our business. These and other factors may cause our actual results to differ materially from any forward-looking statement.

Company Contact:
Green Hygienics Holdings Inc.
1.855.802.0299 Toll Free
IR@GreenHygienics.com

 

https://finance.yahoo.com/news/green-hygienics-holdings-inc-granted-123000162.html


PR Newswire

SAN DIEGO, Oct. 9, 2020




SAN DIEGO, Oct. 9, 2020 /PRNewswire/ -- Green Hygienics Holdings Inc. (OTCQB: GRYN) ("GHH" or the "Company"), is pleased to announce that on September 30, 2020, the Company was granted  the USDA Organic Certification (7 CFR Part 205) for the cultivation and post-harvest processing of industrial hemp by the CCOF (California Certified Organic Farmers), for its' Sol Valley Ranch property, after meeting the CCOF/USDA guidelines for quality and consistency for cultivation, harvest, and processing. This new certification further enables the Company to supply certified organic hemp products to national and international markets. The Company was previously granted USDA Organic Certificate for the 824-acre property, making it the largest single parcel USDA Organic Certified farm in the North American Hemp Industry.

CCOF/USDA certification standards provide specific technical guidance on obtaining high-quality organic plant materials for the sustainable production of the herbal and medicinal products. CCOF/USDA, designed to ensure top quality organic product, consistency, and compliance in production, is a renowned global standard for the industrial hemp certification.

"This certification reflects GHH's ability to produce fully organic grade hemp as well as our adherence to stringent organic operational standards required by USDA. Achieving internationally-recognized quality guidelines will enable us to bring value at every touchpoint of the supply chain," stated Mr. Ron Loudoun, CEO of Green Hygienics Holdings Inc.

About Green Hygienics Holdings Inc.

Green Hygienic Holdings Inc. (OTCQB: GRYN) ("GHH" or the "Company"), a California based innovative technology driven enterprise focused on the high standard cultivation and processing of industrial hemp and manufacturing of pharmaceutical grade bioactive cannabinoids.  The GHH mission is to adhere to the highest standards of operations in consistently delivering safe and premium quality products to consumers as well as to partnering CPG and pharmaceutical companies.

The Company intends to be a leader in compliances and capabilities in the hemp and cannabinoid supply marketplace. Using state of the art technologies, GHH intends to open up a whole new world of novel cannabinoids and targeted bio-delivery technologies never before explored, solving the issues of stability, pharmacokinetics, cell penetration, and bioavailability. We are building a team of visionary agrotechnology, pharmaceutical and life scientists working at the intersection of nutraceutical, cosmeceutical and pharmaceutical technologies with a goal to improve the lives of billions.

For more information, please visit: www.GreenHygienics.com

CAUTIONARY STATEMENT CONCERNING FORWARD LOOKING STATEMENTS This document contains forward-looking statements.  In addition, from time to time, we or our representatives may make forward-looking statements orally or in writing.  We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us.  Such forward-looking statements relate to future events or our future performance, including: our financial performance and projections; our growth in revenue and earnings; and our business prospects and opportunities.  You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as "may," "should," "expects," "anticipates," "contemplates," "estimates," "believes," "plans," "projected," "predicts," "potential," or "hopes" or the negative of these or similar terms.  In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of the Company; our ability to keep pace with new technology and changing market needs; and the competitive environment of our business.  These and other factors may cause our actual results to differ materially from any forward-looking statement.

Company Contact:
Green Hygienics Holdings Inc.
1.855.802.0299 Toll Free
IR@GreenHygienics.com



SAN DIEGO, October 6, 2020 /PRNewswire/ -- Green Hygienic Holdings Inc. (OTCQB: GRYN, GHH) is pleased to announce the appointment of Dr. Levan Darjania, PhD as the Company’s Chief Science Officer.



Dr. Darjania is a seasoned and accomplished R&D professional and program manager with over 26-years’ experience in biotechnology, pharmaceutical drug development (both industry and academia), and a proven track record of success in developing and directing in-house and collaborative R&D programs, and forward-thinking strategic planning capabilities. His research interests include preclinical and clinical R&D, ADME, drug formulation and delivery, pharmacokinetics, toxico-kinetics and bioanalysis, cGLP-IND-enabling studies (Modules 4, 2) for FDA filing. Dr. Darjania is a lead author or co-author of numerous research articles in peer-reviewed journals and presenter or co-presenter at numerous professional conferences and meetings in the U.S. and internationally. Dr. Darjania is also experienced with working with Private Investment Groups to oversee the Global Project Analysis, R&D activities, due diligence process, and scientific communications.




Dr. Levan Darjania held the position of Chief Scientific Officer at Vertical Biosciences and Vice President (Project Analysis and R&D) at MJNA Group, LLC in charge of overseeing global due diligence and research and development in the industrial hemp space in USA, EU, and Latin American countries through its subsidiaries and investment holdings. The Company's products containing naturally occurring cannabinoids, including cannabidiol (CBD), and other products containing CBD-rich hemp oil are formulated for the pharmaceutical, nutraceutical, and cosmeceutical industries, including dietary supplements, prescription-based hemp oil for sale in countries that have legalized its hemp oil for the treatment of various illnesses and conditions, such as Brazil and Mexico, and skincare products.



Prior to moving into the hemp-based nutraceutical industry, as a Director of DMPK at Wellspring Biosciences, Inc., Dr. Darjania oversaw multiple preclinical (PK/PD), clinical (Phase I) and IND enabling regulatory submissions in the U.S. Dr. Darjania has directly supported the successful advancement of 2-clinical drug candidates (ARS-2102 and KO-947) to IND-enabling and first-in-human studies, and successful due diligence in-licensing one oncology drug candidate.




Previously, Dr. Darjania held scientific and R&D leadership positions of increasing responsibility at Takeda Pharmaceuticals, Intellikine Inc, Cylene Pharmaceuticals, Anadys Pharmaceuticals, and Alerion Biomedical where he supported both preclinical and clinical programs in oncology, metabolic disease, and antiviral (HCV/HIV) areas. He has completed post-doctoral research work at the Department of Molecular Cell and Developmental Biology at The University of Texas at Austin and earned his PhD degree in plant biochemistry from Moscow Institute of Biochemistry at The Science Academy of ex-USSR.



"Science and R&D are critical to global competitiveness and Green Hygienics is focused to become the leader in the hemp industry on this front, differentiated from its peers, in order to take the development of the hemp plant and its applications to the next level. With Dr. Darjania's rich R&D experience combined with his passion for hemp-derived bioactive substances, there was no better choice when it came time to name a Chief Scientific Officer.” - said Mr. Ron Loudoun, CEO of Green Hygienic Holding, Inc.




About Green Hygienics Holdings Inc.



Green Hygienic Holdings Inc. (OTCQB: GRYN, GHH), a California based innovative technology-driven enterprise focused on the high standard cultivation and processing of industrial hemp and manufacturing of pharmaceutical-grade bioactive cannabinoids. GHH mission is to adhere to the highest standards of operations in consistently delivering safe and premium quality products to consumers as well as to partnering CPG and pharmaceutical companies.




The Company intends to be a leader in compliance and capabilities in the hemp and cannabinoid supply marketplace. Using state of the art technologies, GHH intends to open up a whole new world of novel cannabinoids and targeted bio-delivery technologies never before explored, solving the issues of stability, pharmacokinetics, cell penetration, and bioavailability. We are building a team of visionary agrotechnology, pharmaceutical and life scientists working at the intersection of nutraceutical, cosmeceutical and pharmaceutical technologies with a goal to improve the lives of billions.



For more information, please visit: www.GreenHygienics.com




CAUTIONARY STATEMENT CONCERNING FORWARD LOOKING STATEMENTS This document contains forward-looking statements. In addition, from time to time, we or our representatives may make forward-looking statements orally or in writing. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Such forward-looking statements relate to future events or our future performance, including: our financial performance and projections; our growth in revenue and earnings; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as "may," "should," "expects," "anticipates," "contemplates," "estimates," "believes," "plans," "projected," "predicts," "potential," or "hopes" or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of the Company; our ability to keep pace with new technology and changing market needs; and the competitive environment of our business. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this document and other statements made from time to time by us or our representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties, and assumptions about us. We are not obligated to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, the forward-looking events discussed in this document, and other statements made from time to time by us or our representatives might not occur.



 



Company Contact:



 



Green Hygienics Holdings Inc.



 



(855) 802-0299



 



IR@GreenHygienics.com